Dr. Asma Basem Dajani, MD

Dr. Dajani practices at American Health Network of Ohio in Hilliard, Ohio.

Dr. Dajani's NPI, 1003013004, was assigned on July 2, 2007. Dr. Dajani holds Ohio license 35.0960033.

Dr. Dajani's primary practice is American Health Network of Ohio, at 3823 Trueman Ct, Hilliard, OH 43026 in Franklin County. The practice phone is (614) 876-9558.

Dr. Dajani's primary practice is American Health Network of Ohio in Hilliard, Ohio. Dr. Dajani is also affiliated with OhioHealth Riverside Methodist Hospital. The medical group on file is American Health Network. Dmand AI also links Dr. Dajani to 3 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dajani practices, 7 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Dajani's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Dajani is board certified in family medicine by the American Board of Family Medicine. Dr. Dajani is licensed in Ohio.

CMS data shows 189 Medicare services from Dr. Dajani across 4 procedure codes in 2024, for 79 Medicare patients. Medicare paid $8,949 for them. Every service was in an office.

CMS counts 79 Medicare patients who saw Dr. Dajani in 2024. The largest group is 75 to 84, with 35 patients. 62% of them have high blood pressure, and 62% have high cholesterol. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dajani's median patient age at 62, with 63% women.

In 2024, Dr. Dajani wrote 1,002 Medicare Part D claims for 240 patients. 86% of them were for generic drugs. CMS names the drug for 585 of them, across 28 drugs with 11 or more claims each, at $44,784 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Dr. Dajani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Dajani to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 31 general payments to Dr. Dajani from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $90.